Minovia Therapeutics
PrivateLast Round
M&A
Jan 30, 2026
Total Funding Raised
$36M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Minovia Therapeutics operates in Healthcare & Life Sciences and is based in Haifa. Its latest recorded funding round was a Corporate Funding round in July 2021.
Minovia Therapeutics is a clinical-stage biotechnology company that develops novel therapies to treat mitochondrial diseases and combat age-related decline using its proprietary Mitochondrial Augmentation Therapy (MAT) platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Minovia Therapeutics Comparables
Compare Minovia Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PAEAN Biotechnology | 80% | |
| cellvie | 78% | |
| Taiwan Mitochondrion Applied Technology Co., Ltd. | 77% |
For institutional investors. Book with your work email.
Minovia Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Jan 30, 2026 | ||||
| Grant | Aug 27, 2025 | ||||
| Corporate Funding | Jul 30, 2021 | ||||
| Series A | Dec 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Minovia Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Launch One Acquisition Corp. | M&A |
| Countdown For A Cure Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 174% MoM, reaching 1.5K.
- Aug 1, 2026
Open roles increased to 12, 3x the trailing average.
For institutional investors. Book with your work email.
Minovia Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Minovia Therapeutics's valuation, stock price, and market status.
Is Minovia Therapeutics a public or private company?
Minovia Therapeutics is a private company.
What is the current stock price of Minovia Therapeutics?
Minovia Therapeutics is a private company, so its shares have no public market price. Caplight tracks Minovia Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Minovia Therapeutics worth (valuation)?
Valuation information for Minovia Therapeutics is not publicly available.
Can I buy Minovia Therapeutics stock?
Minovia Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Minovia Therapeutics's last funding round?
Minovia Therapeutics's most recent funding round was M&A on January 30, 2026.
Who are the main investors in Minovia Therapeutics?
Key investors in Minovia Therapeutics include Launch One Acquisition Corp., Countdown For A Cure Foundation.
Will Minovia Therapeutics IPO soon?
No public IPO plans have been announced for Minovia Therapeutics.
How can I track Minovia Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Minovia Therapeutics's shares on secondary markets.